Linked Life Data

10718783

Source:http://linkedlifedata.com/resource/pubmed/id/10718783

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10718783rdf:typepubmed:Citationlld:pubmed
pubmed-article:10718783lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C0025664lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C1704272lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C1516048lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:10718783lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:10718783pubmed:issue3lld:pubmed
pubmed-article:10718783pubmed:dateCreated2000-4-28lld:pubmed
pubmed-article:10718783pubmed:abstractTextTo establish methodology which rapidly and reliably assesses the effect of an alpha1-adrenoceptor antagonist on peak urine flow rates in men with benign prostatic hyperplasia (BPH). This methodology could then be applied to screening new drugs to treat BPH.lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:languageenglld:pubmed
pubmed-article:10718783pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:citationSubsetIMlld:pubmed
pubmed-article:10718783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10718783pubmed:statusMEDLINElld:pubmed
pubmed-article:10718783pubmed:monthMarlld:pubmed
pubmed-article:10718783pubmed:issn0306-5251lld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:GottesdienerK...lld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:GertzB JBJlld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:LarsonPPlld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:EardleyIIlld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:BoyceMMlld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:CurtisS PSPlld:pubmed
pubmed-article:10718783pubmed:authorpubmed-author:HaesenRRlld:pubmed
pubmed-article:10718783pubmed:issnTypePrintlld:pubmed
pubmed-article:10718783pubmed:volume49lld:pubmed
pubmed-article:10718783pubmed:ownerNLMlld:pubmed
pubmed-article:10718783pubmed:authorsCompleteYlld:pubmed
pubmed-article:10718783pubmed:pagination269-73lld:pubmed
pubmed-article:10718783pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:meshHeadingpubmed-meshheading:10718783...lld:pubmed
pubmed-article:10718783pubmed:year2000lld:pubmed
pubmed-article:10718783pubmed:articleTitleSingle dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia.lld:pubmed
pubmed-article:10718783pubmed:affiliationDivision of Clinical Pharmacology, Merck and Co., Rahway, NJ 07065, USA. sean_curtis@merck.comlld:pubmed
pubmed-article:10718783pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10718783pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10718783pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10718783pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10718783pubmed:publicationTypeMulticenter Studylld:pubmed